Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00VXE
|
|||
Former ID |
DNC010559
|
|||
Drug Name |
N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide
|
|||
Synonyms |
CHEMBL591468; AC1MLZYY; N-(1-adamantyl)phenothiazine-10-carboxamide; Oprea1_167795; ZINC6252722; BDBM50308401; AKOS004107814
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C23H24N2OS
|
|||
Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)NC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64
|
|||
InChI |
1S/C23H24N2OS/c26-22(24-23-12-15-9-16(13-23)11-17(10-15)14-23)25-18-5-1-3-7-20(18)27-21-8-4-2-6-19(21)25/h1-8,15-17H,9-14H2,(H,24,26)
|
|||
InChIKey |
YTNHIPMOCAHDRX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
WikiPathways | Irinotecan Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-2244. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.